Fixed-dose darunavir/cobicistat in pregnancy of HIV-infected women, pharmacokinetic concerns

被引：2
|
作者：
Dash, Prasanta K. [1 ]
Boix, Vicente [2 ,3 ]
机构：
[1] Univ Nebraska Med Ctr, Coll Med, Dept Pharmacol & Expt Neurosci, Omaha, NE 68198 USA
[2] Hosp Gen Univ Alicante, ISABIAL, Unit Infect Dis, Alicante, Spain
[3] Univ Miguel Hernandez, Dept Med Clin, Elche, Spain
来源：
AIDS | 2021年 / 35卷 / 08期
关键词：
IMMUNODEFICIENCY-VIRUS TYPE-1; PROTEASE; PHARMACODYNAMICS; COBICISTAT; DARUNAVIR; GS-9350;
D O I：
10.1097/QAD.0000000000002886
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：1301 / 1303
页数：3
相关论文
共 50 条
  • [1] Evaluating the role of atazanavir/cobicistat and darunavir/cobicistat fixed-dose combinations for the treatment of HIV-1 infection
    Crutchley, Rustin D.
    Guduru, Rakesh C.
    Cheng, Amy M.
    HIV AIDS-RESEARCH AND PALLIATIVE CARE, 2016, 8 : 47 - 65
  • [2] Pharmacokinetic interactions between cobicistat-boosted elvitegravir and darunavir in HIV-infected patients
    Gutierrez-Valencia, Alicia
    Benmarzouk-Hidalgo, Omar J.
    Llaves, Silvia
    Fernandez-Magdaleno, Tamara
    Espinosa, Nuria
    Viciana, Pompeyo
    Lopez-Cortes, Luis F.
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2017, 72 (03) : 816 - 819
  • [3] Use of darunavir in HIV-infected women during pregnancy
    Afonina, L. Yu.
    Voronin, E. E.
    TERAPEVTICHESKII ARKHIV, 2013, 85 (11) : 109 - 114
  • [4] Profile of once-daily darunavir/cobicistat fixed-dose combination for the treatment of HIV/AIDS
    Navarro, Jordi
    Curran, Adrian
    HIV AIDS-RESEARCH AND PALLIATIVE CARE, 2016, 8 : 175 - 182
  • [5] Pharmacokinetics of Darunavir in Fixed-Dose Combination with Cobicistat Compared with Coadministration of Darunavir and Ritonavir as Single Agents in Healthy Volunteers
    Kakuda, Thomas N.
    Opsomer, Magda
    Timmers, Maarten
    Iterbeke, Koen
    Van de Casteele, Tom
    Hillewaert, Vera
    Petrovic, Romana
    Hoetelmans, Richard M. W.
    JOURNAL OF CLINICAL PHARMACOLOGY, 2014, 54 (08): : 949 - 957
  • [6] ECONOMIC EVALUATION OF COBICISTAT-BOOSTED DARUNAVIR IN HIV-INFECTED PATIENTS IN MEXICO
    Guirant Corpi, L.
    Olivares, N.
    Fritz, K.
    Aguirre, A.
    VALUE IN HEALTH, 2017, 20 (09) : A932 - A933
  • [7] Darunavir/cobicistat maintains the effectiveness of darunavir/ritonavir in HIV-infected patients under mono or dual therapy
    Mena, Alvaro
    Cid, Purificacion
    Duenas, Carlos
    Angeles Garcinuno, Maria
    Francisco Lorenzo, Juan
    Margusino, Luis
    Quinones, Marina
    Grande, Carmen
    Rodriguez-Osorio, Iria
    Castro, Angeles
    HIV CLINICAL TRIALS, 2018, 19 (05): : 197 - 201
  • [8] Reduced exposure to darunavir and cobicistat in HIV-1-infected pregnant women receiving a darunavir/cobicistat-based regimen
    Crauwels, H. M.
    Osiyemi, O.
    Zorrilla, C.
    Bicer, C.
    Brown, K.
    HIV MEDICINE, 2019, 20 (05) : 337 - 343
  • [9] Darunavir/cobicistat fixed-dose single tablet (Rezolsta™): a guide to its use in HIV-1 infection in adults in the EU
    Lyseng-Williamson K.A.
    Drugs & Therapy Perspectives, 2015, 31 (3) : 77 - 82
  • [10] Darunavir concentrations in CSF of HIV-infected individuals when boosted with cobicistat versus ritonavir
    Bartels, Hanni
    Decosterd, Laurent
    Battegay, Manuel
    Marzolini, Catia
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2017, 72 (09) : 2574 - 2577
12345